About Pilz BioScience
Pilz BioScience is a company based in Vancouver (Canada) founded in 2020 was acquired by Nova Mentis in November 2020. Pilz BioScience offers products and services including Data Analysis, Data Consulting, Data Security, Machine Learning, and AI Solutions. Pilz BioScience operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Nova Mentis
(Nov 02, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pilz BioScience
Pilz BioScience offers a comprehensive portfolio of products and services, including Data Analysis, Data Consulting, Data Security, Machine Learning, and AI Solutions.
Unlocks insights from data using advanced techniques.
Provides expert advice on data strategies and implementations.
Protects information and privacy in digital environments.
Offers tools for predictive analytics and automation.
Delivers innovative AI applications for business needs.
Funding Insights of Pilz BioScience
Detailed funding history for Pilz BioScience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Pilz BioScience
Pilz BioScience has secured backing from 1 investor. Prominent investors backing the company include Nova Mentis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRO offering services for drug discovery & development in neurology
|
Locked | Locked | Locked |
Investor details for Pilz BioScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pilz BioScience
Investment portfolio details for Pilz BioScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pilz BioScience
Detailed financials for Pilz BioScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pilz Bioscience Comparisons
Peer comparison for Pilz BioScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pilz BioScience
Pilz BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Pilz BioScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pilz Bioscience
Complete news archive for Pilz BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pilz BioScience
Pilz BioScience was founded in 2020.
Pilz BioScience is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Pilz BioScience was founded in 2020 and is based in Vancouver, Canada. Operations focus on the biotechnology sector, where hallucinogenic compounds such as psilocybin are derived from mushrooms to create drugs for neuroinflammatory conditions, including Autism Spectrum Disorder. Proprietary psychedelics, including PLZ-1013 and PLZ-1015, are currently in the pre-clinical phase of development.
Pilz BioScience's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Pilz BioScience offers Data Analysis, Data Consulting, Data Security, Machine Learning, and AI Solutions.
Pilz BioScience has 1 investor. Key investors include Nova Mentis.